Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.

Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB.

Am J Hum Genet. 2007 Feb;80(2):273-90. Epub 2006 Dec 21.

2.

Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes.

Christensen TE, Callis KP, Papenfuss J, Hoffman MS, Hansen CB, Wong B, Panko JM, Krueger GG.

J Invest Dermatol. 2006 Nov;126(11):2397-403. Epub 2006 Jul 20.

3.

Impact of obesity and smoking on psoriasis presentation and management.

Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG.

Arch Dermatol. 2005 Dec;141(12):1527-34.

PMID:
16365253
4.

Development and use of alefacept to treat psoriasis.

Krueger GG, Callis KP.

J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S87-97. Review.

PMID:
12894131
5.

Efficacy of acitretin and commercial tanning bed therapy for psoriasis.

Carlin CS, Callis KP, Krueger GG.

Arch Dermatol. 2003 Apr;139(4):436-42.

PMID:
12707089
6.
7.

Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus.

Spach DH, Callis KP, Paauw DS, Houze YB, Schoenknecht FD, Welch DF, Rosen H, Brenner DJ.

J Clin Microbiol. 1993 Mar;31(3):692-4.

Supplemental Content

Loading ...
Support Center